OHSU

David Roalf

Ph.D. Graduate (2010)

David R. RoalfUndergraduate Education

BS (2001) Neuroscience, College of William and Mary, Williamsburg VA

Training Dates at OHSU

2005 -2010

Mentor

Jeri S. Janowsky, Ph.D.

Dissertation Title

It's not fair: Behavioral and neural evidence that equity influences social economic decisions in healthy older adults (Mentor: Jeri S. Janowsky, Ph.D.)

Contact

droalf@gmail.com

Current Position

Post-doctoral Fellow (T32)
Department of Psychiatry, Neuropsychiatry
University of Pennsylvania
Philadelphia, Pennsylvania
Mentors: Raquel Gur, M.D./Ph.D. & Ruben Gur, Ph.D.

Honors and Awards

  • (2008) OHSU Student Research Forum Best Poster
  • (2009) Recipient of the OHSU School of Medicine Alliance Award
  • (2009) Recipient of the OHSU Ginger Ashworth Foundation Award
  • (2009) Portland, OR University Club Nominee - Portland Chapter
  • (2010) OHSU Student Research Forum Best Oral Presentation ($200)
  • (2013) Human Brain Mapping Trainee Travel Award ($700)

Fellowships

  • (2001) State of Virginia Governor's Fellowship
  • (2006 - 2008) NIH T32 Neuroscience of Aging Pre-doctoral Training Fellowship (PI: Janowsky)
  • (2007) University of Michigan fMRI Training Course Fellow
  • (2008) N.L. Tartar Research Fellowship (OHSU)
  • (2008) University of Pittsburgh/Carnegie Mellon Multimodal Neuroimaging Workshop (MNTP) Fellow
  • (2009) University of Michigan Decision Neuroscience Training Workshop Fellow
  • (2010 - present) NIH T32 Neuropsychiatry Research Training Program (PI: Gur)

Publications

In Press

Cai K, Singh A, Roalf DR, Reddy Nanga RP, Haris M, Hariharan H, Gur RC, Reddy R (in press) Mapping glutamate in subcortical brain structures using high-resolution GluCEST MRI. NMR in Biomedicine.

Roalf DR, Gur RC, Almasy L, Richard J, Gallagher RS, Prasad K, Wood J, Pogue-Geile MF, Nimgaonkar VL, Gur RE (in press) Neurocognitive performance stability in a multiplex multigenerational study of schizophrenia. Schizophrenia Bulletin.

Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE (in press) Comparative accuracies of two common screening instruments for the classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimer's & Dementia.

Publications (2003 - present)

Turetsky BI, Moberg PJ, Roalf DR, Arnold SE, Gur RE (2003) Decrements in volume of anterior ventromedial temporal lob and olfactory dysfunction in schizophrenia. Archives of General Psychiatry. 60, 1993-1200.

Moberg PJ, Roalf DR, Gur RE, Turetsky BI (2004) Smaller nasal volumes as stigmata of aberrant neurodevelopment in schizophrenia. American Journal of Psychiatry. 161(12), 2314-2316.

Moberg PJ, Roalf DR, Balderston CC, Kanes SJ, Gur RE, Turetsky BI (2005) Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members. American Journal of Psychiatry. 162(4), 788-790.

Robinson KM, Dennison AC, Roalf DR, Noorigian JV, Clanci H, Bunting-Perry L, Kleiner-Fisman G, Moberg P, Duda J, Stern ME (2005) Falling risk factors in Parkinson's disease: Pilot data and review of the literature. NeuroRehabilitation. 20,169-182.

Roalf DR, Lowery N, Turetsky BI (2006) Behavioral and physiological findings of gender differences in global-local visual processing. Brain & Cognition. 60(1): 32-42.

Moberg PJ, Arnold SE, Roalf DR, Balderston C, Abbazia J, Kohler CG, Gur RE, Turetsky BI (2006) Apolipoprotein E genotype and odor identification in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences. 18, 231-233.

Roalf DR,Turetsky BI, Owzar K, Balderston CC, Johnson SC, Brensinger CM, Gur RE, Siegel S, Moberg PJ (2006) Unirhinal olfactory function in patients with schizophrenia and first-degree relatives. Journal of Neuropsychiatry and Clinical Neurosciences. 18, 389-396.

Moberg PJ, Arnold SE, Doty RL, Gur RE, Balderston CC, Roalf DR, Gur RC, Kohler CG, Kanes SJ, Siegel SJ, Turetsky BI (2006) Olfactory functioning in schizophrenia: Relationship to clinical, neuropsychological, and volumetric MRI measures. Journal of Clinical and Experimental Neuropsychology. 28, 1444-1461.

Moberg PJ, McGue C, Kanes SJ, Roalf DR, Balderston CC, Gur RE, Kohler CG, Turetsky BI (2007) Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: Relationship to clinical symptomatology and psychophysical olfactory performance. Schizophrenia Research. Feb; 90(1-3): 221-228.

Moberg PJ, Balderston CC, Rick JH, Roalf DR, Weintraub D, Kleiner-Fisman G, Stern MB, Duda JE (2007) Phenylthiocarbamide (PTC) perception in Parkinson's disease. Cognitive and Behavioral Neurology. Sept; 20(3): 145-148.

Pruis TA, Roalf DR, Janowsky SJ (2009) Hormone therapy does not modify emotion-induced activity in older women. Hormones & Behavior. Nov;56(5): 539-47. PMC2783864.

Roalf DR, Pruis TA, Stevens AA, Janowsky JS (2011) More is less: Emotion induced prefrontal cortex activity habituates in aging. Neurobiology of Aging. Sep;32(9): 1634-1650. PMC2891805.

Roalf DR, Mitchell SH, Harbaugh WT, Janowsky JS (2012) Risk, reward, and economic decision-making in aging. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. May;67(3): 289-98. PMC3325085.

Roalf DR, Ruparel K, Verma R, Elliott MA, Gur RE, Gur RC (2013) White matter organization and neurocognitive performance variability in schizophrenia. Schizophrenia Research. Jan;143(1): 172-178. PMC3540127 [Available 2014/1/1]

Book/Encyclopedia Chapters

Janowsky JS, Roalf DR (2009) Hormones and Memory. In P. Hof & C. Mobbs (Eds.), The Handbook of the Neuroscience of Aging (pp. 619-622). San Diego CA: Academic Press.

Last Updated on June 4, 2013